Loading research…
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (LSE: CURE)
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is listed on LSE under the symbol CURE. This listing is quoted in USD. The issuer is VanEck ETP AG. Its asset class is equity. The stated benchmark is MVIS Global Future Healthcare ESG Index - Benchmark TR Net. Review available holdings, fees and performance below. Figures retain their observation dates and currencies.
Fund profile
- Exchange
- LSE
- Trading currency
- USD
- Issuer
- VanEck ETP AG
- Brand
- VanEck
- Asset class
- Equity
- Category
- Sector
- Investment focus
- Theme
- Strategy
- Vanilla
- Benchmark
- MVIS Global Future Healthcare ESG Index - Benchmark TR Net
- Domicile
- Ireland
- Holdings region
- Global
- ISIN
- IE000B9PQW54
- FIGI
- BBG019FNNFP6
- Security classification
- CEOGES
- Inception date
- 2022-09-02
- UCITS compliance
- Compliant
Data notes
Scores, valuation models and research metrics use dated FOLITIC research. Dates and currencies remain attached to their observations. Missing values are shown as a dash.
Market quotes and charts use the separate market-data display. Saved research prices and model comparisons are not live quotes. Model ranges represent sensitivity scenarios, not confidence intervals or price guarantees.
Listings on different exchanges and different share classes are kept separate. No currency conversion is applied to saved research values.